Syncora P/E
Cos'è P/E di Syncora?
P/E di Syncora Holdings Ltd. è N/A
Qual è la definizione di P/E?
Il rapporto prezzo / utili è il rapporto tra il prezzo delle azioni di una società e l'utile per azione della società calcolato su dodici mesi.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E di aziende nel Finance settore su OTC rispetto a Syncora
Cosa fa Syncora?
SHL Holdings Ltd. does not have significant operations. It was previously engaged in the provision of financial guarantee insurance and reinsurance, and credit enhancement for the obligations of debt issuers. The company was formerly known as Syncora Holdings Ltd. and changed its name to SHL Holdings Ltd. in December 2020. SHL Holdings Ltd. was founded in 2006 and is headquartered in Hamilton, Bermuda.
Aziende con p/e simili a Syncora
- Scotgold Resources ha P/E di N/A
- FSD Pharma Inc ha P/E di N/A
- Revolution Bars Plc ha P/E di N/A
- First Foods ha P/E di N/A
- Tritent International ha P/E di N/A
- Navidea Biopharmaceuticals Inc ha P/E di N/A
- Syncora ha P/E di N/A
- YogaWorks ha P/E di N/A
- Naked Brand ha P/E di N/A
- Andover Mining ha P/E di N/A
- Le Chateau ha P/E di N/A
- Bonavista ha P/E di N/A
- Sorrento Therapeutics ha P/E di N/A